Kimberly-Clark Corp (KMB)

KMB (NYSE:Consumer Non-Durables) EQUITY
$107.55
pos +0.00
+0.00%
Today's Range: 107.35 - 108.61 | KMB Avg Daily Volume: 1,371,600
Last Update: 07/02/15 - 4:01 PM EDT
Volume: 0
YTD Performance: -6.92%
Open: $0.00
Previous Close: $107.85
52 Week Range: $99.20 - $119.01
Oustanding Shares: 364,099,179
Market Cap: 39,268,096,455
6-Month Chart
TheStreet Ratings Grade for KMB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 1 1
Moderate Buy 1 1 1 1
Hold 9 9 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.58 2.58 2.75 2.75
Latest Dividend: 0.88
Latest Dividend Yield: 3.26%
Dividend Ex-Date: 06/03/15
Price Earnings Ratio: 27.51
Price Earnings Comparisons:
KMB Sector Avg. S&P 500
27.51 27.60 26.13
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.50% -3.49% 28.19%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.05 -0.02
Net Income -28.20 -0.08 -0.03
EPS -27.00 0.01 0.00
Earnings for KMB:
EBITDA 3.84B
Revenue 19.72B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.36 $1.51 $5.75 $6.21
Number of Analysts 7 6 9 9
High Estimate $1.39 $1.56 $5.80 $6.31
Low Estimate $1.33 $1.48 $5.68 $6.05
Prior Year $1.49 $1.61 $5.51 $5.75
Growth Rate (Year over Year) -8.92% -5.90% 4.44% 7.90%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
It's a silent carnage for now, but worth watching.
Higher timeframe swing traders can look to enter HON around $100.
Bullish
May 13, 2015 | 7:56 AM EDT
KMB was upgraded from Equal-weight to Overweight, Barclays said. $124 price target. Organic sales growth should outperform the industry...
Here's what stocks would do well with a strong dollar.
Update
Apr 30, 2015 | 6:34 AM EDT
KMB - Kimberly-Clark Corp Annual Shareholders Meeting - 11AM
March quarter earnings take a front seat.
Biotech companies are saying, "I do."
U.S. stocks follow Europe's lead.
The jobs report actually indicates the dollar has peaked. 
That portfolio managers haven't figured this out yet is a negative.

Columnist Conversations

Sorry folks. I received a few queries concerning my earlier note on IMF nullification of the Greek referendum ...
It appears that the International Monetary Fund has preemptively nullified the referendum scheduled for this S...
Earlier today we added some IWM puts, this being the 'weakest' performing index this week, and ready to break ...
Forget Greece, forget economic data, forget everything. Just give me my burrito. CMG continues chugging high...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.